CHD
Church & Dwight Co., Inc.
CHD's fundamentals are mixed: it turned 16% of its revenue into free cash flow, while earnings per share grew only 2.2%. At 34x earnings, it's trading in line with its usual 32x. Analysts expect earnings growth.
CHD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Unavailable | |
| Healthy |
CHD's profitability and balance sheet are currently healthy, and its revenue is stable. There isn't enough data to rate its cash flow.
CHD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $88.68 | -21% |
| Forward | 28x | $112 | — |
| Fair | 31x | $102 | -8.4% |
| Current | 34x | $112 | — |
| Expensive | 47x | $153 | +37% |
Historical ranges are pointers, not guarantees.
CHD's PE is in its expensive range at 34x. If earnings grow as analysts expect, today's price would be 28x next year's earnings, in its cheap range.
CHD Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect CHD's earnings to grow and its profitability to improve, with its revenue holding steady.
CHD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.98 | +23% |
| Q3 2026 | $3.25 | +2.2% |
| Q2 2026 | $3.11 | +47% |
| Q1 2026 | $3.04 | +30% |
| Q4 2025 | $3.02 | +27% |
| Q3 2025 | $3.18 | +42% |
| Q2 2025 | $2.12 | -35% |
| Q1 2025 | $2.33 | -26% |
| Q4 2024 | $2.37 | -22% |
CHD earned $3.25 per share over the past year, up 2.2% from the year before.
CHD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +1% |
| Q2 2026 | $1.5B | +1.6% |
| Q1 2026 | $1.5B | +0.1% |
| Q4 2025 | $1.6B | +3.9% |
| Q3 2025 | $1.6B | +5% |
| Q2 2025 | $1.5B | -0.3% |
| Q1 2025 | $1.5B | -2.4% |
| Q4 2024 | $1.6B | +3.5% |
CHD's revenue grew through 2023 and has held roughly level since: $1.6B last quarter, up 1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +2.1 points |
| Q2 2026 | 18% | +0.7 points |
| Q1 2026 | 20% | -0.3 points |
| Q4 2025 | 16% | -0.1 points |
| Q3 2025 | 16% | +22 points |
| Q2 2025 | 17% | -4.9 points |
| Q1 2025 | 20% | -0.2 points |
| Q4 2024 | 16% | +2.1 points |
CHD's operating margin was 18% last quarter, up 2.1 points from the same quarter a year ago.
CHD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $237.7M | +78% |
| Q3 2024 | $315.4M | +39% |
| Q2 2024 | $206.6M | +4.4% |
| Q1 2024 | $216.7M | -13% |
| Q4 2023 | $133.5M | -51% |
| Q3 2023 | $227.6M | +38% |
| Q2 2023 | $197.9M | +47% |
| Q1 2023 | $248.1M | +81% |
CHD's free cash flow has been positive every quarter for six years: $987M over the past year, up 13% from the year before.
CHD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +500K shares |
| 1 year | -1.9% | -4.5M shares |
| 3 years | -4% | -10M shares |
| 5 years | -4.4% | -11.1M shares |
| Available history | -5.3% | -13.4M shares |
CHD has 239M diluted shares, down 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $37.1M |
| Q4 2025 | $300M |
| Q3 2025 | $300M |
| Q4 2022 | — |
| Q4 2021 | $445.1M |
| Q4 2020 | $300M |
| Q3 2020 | — |
| Q2 2020 | — |
CHD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 1.2x | Healthy |
CHD's net debt is about 1.3 years of its operating earnings (EBITDA), down from 1.5 years a year ago.
CHD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.9 | Neutral |
| Stochastic | 80.0 | Neutral |
CHD's weekly RSI is 69 (neutral) and its Stochastic is 80 (neutral).
CHD PE vs Consumer Defensive Sector
| Metric | CHD | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 19x | 76% above |
| PE % | 71 | 18 | 53 pts above |
CHD is trading at 34x earnings, a 76% premium to the Consumer Defensive sector's median of 19x.
CHD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $103.4 | 8.1% above |
| 20 week MA | $100.4 | 11% above |
| 50 week MA | $96.8 | 15% above |
| 100 week MA | $97.2 | 15% above |
| 200 week MA | $97.4 | 15% above |
CHD has climbed back above all five of its weekly moving averages, and it's now 15% above its 200-week average.
CHD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $70.7 | $86.9 | +23% |
| 2021 | $86.9 | $99.5 | +15% |
| 2022 | $99.5 | $82.1 | -18% |
| 2023 | $82.1 | $94.6 | +15% |
| 2024 | $94.6 | $105.9 | +12% |
| 2025 | $105.9 | $85.4 | -19% |
| 2026 YTD | $85.4 | $111.7 | +31% |
CHD has finished higher in four of the last six years. It's up 31% so far in 2026.